Cvi Holdings, LLC Chemomab Therapeutics Ltd. Transaction History
Cvi Holdings, LLC
- $11.5 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding CMMB
# of Institutions
18Shares Held
3.72MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$2.04 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3900KShares$1.05 Million0.26% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$676,6000.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$249,2700.03% of portfolio
-
Morgan Stanley New York, NY117KShares$137,0770.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $13.4M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...